1-10 of 10
Julie Kanter
Close
Sort by
Journal Articles

Costs and impact of disease in adults with sickle cell disease: a pilot study

Sophie Lanzkron, Nicole Crook, Joanne Wu, Sarah Hussain, Randall G. Curtis, Derek Robertson, Judith R. Baker, Diane Nugent, Amit Soni, Jonathan C. Roberts, Megan M. Ullman, Julie Kanter, Michael B. Nichol
Journal: Blood Advances
Blood Adv (2024) 8 (14): 3629–3638.
https://doi.org/10.1182/bloodadvances.2023012477
Published: 2024
Journal Articles

DISPLACE study shows poor quality of transcranial doppler ultrasound for stroke risk screening in sickle cell anemia

Clinical Trials & Observations
Kimberly A. Davidow, Robin E. Miller, Shannon M. Phillips, Alyssa M. Schlenz, Martina Mueller, Monica L. Hulbert, Lewis L. Hsu, Neha Bhasin, Robert J. Adams, Julie Kanter
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3444–3452.
https://doi.org/10.1182/bloodadvances.2024012631
Published: 2024
Journal Articles

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease

Clinical Trials & Observations
Julie Kanter, R. Clark Brown, Cynthia Norris, Santosh M. Nair, Abdullah Kutlar, Deepa Manwani, Nirmish Shah, Chiaki Tanaka, Shankaranand Bodla, Gessami Sanchez-Olle, Urs Albers, Darla Liles
Journal: Blood Advances
Blood Adv (2023) 7 (6): 943–952.
https://doi.org/10.1182/bloodadvances.2022008209
Published: 2023
Includes: Multimedia, Supplemental data
Journal Articles

Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years

Clinical Trials & Observations
Mohsen S. Elalfy, Mona Hamdy, Amal El-Beshlawy, Fatma S. E. Ebeid, Mohamed Badr, Julie Kanter, Baba Inusa, Amira A. M. Adly, Suzan Williams, Yurdanur Kilinc, David Lee, Caroline Fradette, Anna Rozova, Noemi Toiber Temin, Fernando Tricta, Janet L. Kwiatkowski
Journal: Blood Advances
Blood Adv (2023) 7 (4): 611–619.
https://doi.org/10.1182/bloodadvances.2021006778
Published: 2023
Includes: Supplemental data
Journal Articles

Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study

Clinical Trials & Observations
Janet L. Kwiatkowski, Mona Hamdy, Amal El-Beshlawy, Fatma S. E. Ebeid, Mohammed Badr, Abdulrahman Alshehri, Julie Kanter, Baba Inusa, Amira A. M. Adly, Suzan Williams, Yurdanur Kilinc, David Lee, Fernando Tricta, Mohsen S. Elalfy
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1243–1254.
https://doi.org/10.1182/bloodadvances.2021004938
Published: 2022
Includes: Supplemental data
Journal Articles

GRNDaD: big data and sickle cell disease

Sophie Lanzkron, Deepa Manwani, Payal Desai, Julie Kanter, Jane Little
Journal: Blood Advances
Blood Adv (2022) 6 (3): 1088.
https://doi.org/10.1182/bloodadvances.2021005282
Published: 2022
Includes: Supplemental data
Journal Articles

American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation

Julie Kanter, Robert I. Liem, Françoise Bernaudin, Javier Bolaños-Meade, Courtney D. Fitzhugh, Jane S. Hankins, M. Hassan Murad, Julie A. Panepinto, Damiano Rondelli, Shalini Shenoy, John Wagner, Mark C. Walters, Teonna Woolford, Joerg J. Meerpohl, John Tisdale
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3668–3689.
https://doi.org/10.1182/bloodadvances.2021004394
Published: 2021
Includes: Supplemental data
Journal Articles

Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects

Julie Kanter, Wally R. Smith, Payal C. Desai, Marsha Treadwell, Biree Andemariam, Jane Little, Diane Nugent, Susan Claster, Deepa G. Manwani, Judith Baker, John J. Strouse, Ifeyinwa Osunkwo, Rosalyn W. Stewart, Allison King, Lisa M. Shook, John D. Roberts, Sophie Lanzkron
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3804–3813.
https://doi.org/10.1182/bloodadvances.2020001743
Published: 2020
Journal Articles

Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease

Clinical Trials & Observations
Matthew M. Hsieh, Melissa Bonner, Francis John Pierciey, Jr, Naoya Uchida, James Rottman, Laura Demopoulos, Manfred Schmidt, Julie Kanter, Mark C. Walters, Alexis A. Thompson, Mohammed Asmal, John F. Tisdale
Journal: Blood Advances
Blood Adv (2020) 4 (9): 2058–2063.
https://doi.org/10.1182/bloodadvances.2019001330
Published: 2020
Journal Articles

Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)

Clinical Trials & Observations
Ahmed A. Daak, Carlton D. Dampier, Beng Fuh, Julie Kanter, Ofelia A. Alvarez, L. Vandy Black, Melissa A. McNaull, Michael U. Callaghan, Alex George, Lynne Neumayr, Lee M. Hilliard, Fredrick Sancilio, Adrian L. Rabinowicz, Matthew M. Heeney
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1969–1979.
https://doi.org/10.1182/bloodadvances.2018021444
Published: 2018
Includes: Supplemental data